reclast infusion center analysis august 4, 2008
DESCRIPTION
Reclast Infusion Center Analysis August 4, 2008. Key Findings. 93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district. 45.1K targets have infusion access within 10 miles - PowerPoint PPT PresentationTRANSCRIPT
2
Key Findings
93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district.• 45.1K targets have infusion access within 10 miles• 3.3K targets do not have infusion access within 10 miles
There is a positive relationship between Reclast sales and the number of infusion centers • As the number of infusion centers increases, Reclast sales increase
4
Geigy Region: Atlanta 5,821 targets have infusion access within 10 miles (black dots)
428 targets do not have infusion access within 10 miles (red triangles)
5
Geigy Region: Boston 4.606 targets have infusion access within 10 miles (black dots)
218 targets do not have infusion access within 10 miles (red triangles)
6
Geigy Region: Chicago 7,426 targets have infusion access within 10 miles (black dots)
550 targets do not have infusion access within 10 miles (red triangles)
7
Geigy Region: Cincinnati 6,339 targets have infusion access within 10 miles (black dots)
350 targets do not have infusion access within 10 miles (red triangles)
8
Geigy Region: Dallas 5,661 targets have infusion access within 10 miles (black dots)
573 targets do not have infusion access within 10 miles (red triangles)
9
Geigy Region: Morristown 4,828 targets have infusion access within 10 miles (black dots)
278 targets do not have infusion access within 10 miles (red triangles)
10
Geigy Region: Raleigh 5,141 targets have infusion access within 10 miles (black dots)
512 targets do not have infusion access within 10 miles (red triangles)
11
Geigy Region: San Ramon 5,109 targets have infusion access within 10 miles (black dots)
307 targets do not have infusion access within 10 miles (red triangles)
15
Bone/Uro Districts: Correlation between Reclast sales and Reclast Ready sites is 0.60
There is a positive association between Reclast sales and Reclast Ready sites
0
100
200
300
400
500
600
700
KA
NS
AS
CIT
Y
NA
SH
VIL
LE
AT
LA
NT
A
DE
TR
OIT
TA
MP
A
PIT
TS
BU
RG
H
CH
ICA
GO
HO
US
TO
N
BO
ST
ON
SA
N F
RA
NC
ISC
O
WA
SH
ING
TO
N D
C
PH
ILA
DE
LP
HIA
DA
LL
AS
LO
S A
NG
EL
ES
NE
W Y
OR
K
Re
cla
st R
ea
dy
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
%R
ecla
st S
ale
s/%
BP
TR
xs
Reclast Ready %Reclast Sales/%BP TRxs
Data ending June 2008
17
Bone/Uro Districts: Correlation between Reclast sales and estimated 65+ women patients per Reclast Ready facility is -0.76 There is a positive association between sales and Reclast Ready sites
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
KA
NS
AS
CIT
Y
NA
SH
VIL
LE
AT
LA
NT
A
DE
TR
OIT
TA
MP
A
PIT
TS
BU
RG
H
CH
ICA
GO
HO
US
TO
N
BO
ST
ON
SA
N F
RA
NC
ISC
O
WA
SH
ING
TO
N D
C
PH
ILA
DE
LP
HIA
DA
LL
AS
LO
S A
NG
EL
ES
NE
W Y
OR
K
Pa
tie
nts
/RR
Fa
cility
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
%R
ecla
st S
ale
s/%
BP
TR
xs
Est. 65+ Women Patient per RR Facility %Reclast Sales/%BP TRxs
Estimated 65+ Women Patients = 55% of 65+ Women
Data ending June 2008
18
Bone-Uro Districts: Correlation between estimated 65+ women patients and oral BP TRxs is 0.90 but correlation between 65+ Women patients and Reclast sales is only 0.42
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000K
AN
SA
S C
ITY
NA
SH
VIL
LE
AT
LA
NT
A
DE
TR
OIT
TA
MP
A
PIT
TS
BU
RG
H
CH
ICA
GO
HO
US
TO
N
BO
ST
ON
SA
N F
RA
NC
ISC
O
WA
SH
ING
TO
N D
C
PH
ILA
DE
LP
HIA
DA
LL
AS
LO
S A
NG
EL
ES
NE
W Y
OR
K
Ora
l B
P T
Rxs &
Est. 6
5+
W P
atie
nts
$0
$2
$4
$6
$8
$10
$12
Millio
ns
Re
cla
st S
ale
s
Est. 65+ Women Patients BPTRX Reclast Sales
Estimated 65+ Women Patients = 55% of 65+ Women
Data ending June 2008